We are a clinical stage company developing a first-in-class therapeutic that will cure a chronic infection that affects between 5-9% of women globally.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free